Account
Watchlists
Bookmarks
Pricing
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Investor Presentation
Q2 FY25
Investor Presentation
Q4 FY24
Investor Presentation
Q3 FY24
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
4
Neutral
9
Bullish
1
Bearish
35
Neutral
9
Bullish
2
Bearish
31
Neutral
0
Bullish
1
Price, EPS and Revenue Projections
Strong Buy
1
Buy
3
Hold
1
Sell
0
Strong Sell
0
updated on
Dec 03, 2025
No. of Analysts
1Y Price Target
Q3 EPS Estimate
Q3 Revenue Estimate
Market Cap
₹ 1,060 Cr
P/E
25.42
Get In-depth insights on EPS and Revenue forecasts
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
74.55 | 1,227 Cr | 40.43 | 6.73 | 0.00 | 16.69 | 19.54 | 10.15 | |
141.40 | 1,060 Cr | 25.42 | 5.35 | 2.71 | 26.36 | 23.95 | 0.00 | |
331.35 | 514 Cr | 33.92 | 4.89 | 0.00 | 19.24 | 34.76 | 21.01 | |
188.10 | 370 Cr | 27.22 | 4.19 | 0.00 | 15.39 | 17.02 | 7.89 | |
131.70 | 269 Cr | 404.06 | 4.44 | 0.00 | 1.11 | 2.57 | 0.94 | |
120.50 | 199 Cr | 69.25 | 3.71 | 0.00 | 6.13 | 8.59 | 5.07 | |
83.50 | 195 Cr | 83.50 | 1.96 | 0.00 | 1.13 | 2.34 | 2.08 |
GPT Healthcare Limited operates a chain of mid-sized multispecialty hospitals under the 'ILS Hospitals' brand, focusing on secondary and tertiary care across Eastern India.
The company has registered a commendable year-on-year increase in revenue by 12.5% for Q2 FY26, propelled by an expanding hospital network and diversified specialty care services.
In H1 FY26, the company's EBITDA reached INR43 crores but faced pressure with margins dropping to 18.8% due to initial losses incurred by the new Raipur hospital.
GPT Healthcare is pursuing an aggressive expansion strategy, with plans to commission a 150-bed hospital in Jamshedpur by the end of FY27, propelling its aim to reach a 1,000-bed capacity.
The innovative asset-light model in setting up hospitals at strategic locations aids in maintaining high returns on capital and quick breakeven timelines, fostering sustainable growth.
Healthcare
Hospitals / Medical Services
1,060 Cr
Low Risk
25.4
62.2
0.9
5.4
190.55
126.15
Sales CAGR
1Y
38.99%
3Y
6.46%
5Y
13.96%
10Y
—
Profit CAGR
1Y
97.53%
3Y
6.21%
5Y
35.43%
10Y
—
ROE
TTM
26.36%
3Y
21.64%
5Y
21.59%
10Y
—
ROCE
TTM
23.95%
3Y
25.89%
5Y
24.04%
10Y
—
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
MODERATE RISK
